Butropium

DB15968ExperimentalSmall molecule

Butropium is a medication indicated to treat pain caused by gastrointestinal inflammation and ulcers, or diseases of the gallbladder. A medication used to treat pain and swelling in the digestive tract.

Mechanism: Butropium is an anticholinergic and antispasmodic drug. While its exact mechanism of action of butropium has not been fully elucidated, it is likely from the antagonism at muscarinic receptors.
Curator reviewed · 2 references
Formula / weight: C₂₈H₃₈NO₄ · 452.614 g/mol (avg)

Resolves to

Compound

UNII7WSK03KXXWCAS107080-63-7ChEBI145697

Structure

InChIKeyALVDDLOWVXJXCD-OTSXCXJCSA-NSMILESCCCCOC1=CC=C(C[N+]2(C)[C@H]3CC[C@@H]2C[C@@H](C3)OC(=O)[C@H](CO)C2=CC=CC=C2)C=C1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Structured indicationsCondition, population, route and combination as fields, not prose

7ContraindicationsEach with its own population and attribute set

1Marketed productAcross 1 country and 1 labeller

4+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Butropium, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account